Hao Zhang

Director/Miembro de la Junta en HaploX Investment Holding Ltd. .

46 años

Consumer Services

Commercial Services

Perfil

Hao Zhang currently works at HaploX Investment Holding Ltd., as Non-Executive Director from 2023.
Mr. Zhang received his graduate degree in 2006 from Tsinghua University and undergraduate degree in 2000 from Fudan University.

Cargos activos de Hao Zhang

Empresas	Cargo	Inicio
HaploX Investment Holding Ltd. HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong.	Director/Miembro de la Junta	29/01/2023

Todos los cargos activos de Hao Zhang

Formación de Hao Zhang.

Fudan University	Undergraduate Degree
Tsinghua University	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hao Zhang.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
HaploX Investment Holding Ltd. HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong.	Commercial Services